List of partners

The content of the below mentioned websites, sessions or exhibition stands does not necessarily reflect the opinion of ECNP, nor does it engage its responsibility.

In alphabetical order: 

EU-funded project supported by ECNP
Virtual exhibition

AIMS-2-TRIALS is a European research programme exploring the biology of autism, how it develops and how this can vary, to develop new medicines tailored to individual needs. It is also building a network to connect researchers, clinicians and the autism community and exploring European policies to better support autistic people.

AIMS-2-TRIALS EU-funded project supported by ECNP 

ALBA Network
Virtual exhibition

The ALBA Network aims to promote equity and diversity in the brain sciences. The goal of ALBA is to establish a global network in order to share best practices and provide better visibility, networking and mentoring opportunities to scientists from underrepresented groups in brain research.
Join us:


ALBA Network  

Virtual exhibition
Industry Satellite Symposium: ISS.09 — Invitation flyer

Angelini Pharma is committed to give hope to patients in the areas of CNS (included pain), Rare Diseases and Consumer Health. Angelini Pharma has an extensive R&D programs, world-class manufacturing and marketing of both active ingredients and branded drugs.



EQIPD ―European Quality In Preclinical Data
EU-funded project supported by ECNP
Virtual exhibition

While high risk of failure is an inherent part of developing innovative therapies, it can be reduced by adherence to evidence-based rigorous research practices. EQIPD, a project funded by IMI2 JU, has developed a novel and free-to-use preclinical research quality system, designed to boost innovation through the generation of robust and reliable preclinical data while being lean, effective and not becoming a burden that could negatively impact the freedom to explore scientific questions. EQIPD has also developed tools to support users in implementing the system. Further, EQIPD is preparing training support and assessment services for those who implement the quality system and seek formal accreditation.



Virtual exhibition

EUFAMI is an international NGO based in Belgium committed to improving the care for and welfare of people with mental ill health. Our mission is to represent at the European level all family members of persons affected by mental ill health and to protect their rights and interests.



European Brain Council (EBC)
Virtual exhibition

The European Brain Council is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners. Its main mission is to promote brain research with the ultimate goal of improving the lives of the estimated 179 million Europeans living with brain conditions.


European Brain Council 

European Neuropsychopharmacology Journal (ENP)
Virtual exhibition

European Neuropsychopharmacology is the official ECNP journal. Encompassing basic and clinical and research on the effects of centrally acting agents in the broadest sense, the journal showcases the best international research advancing our understanding of brain function and human behaviour and enabling translation into improved treatments and enhanced public health.



European Psychiatric Association (EPA)
Virtual exhibition

With active individual members in 88 countries and 44 National Psychiatric Association Members who represent more than 80,000 psychiatrists, the European Psychiatric Association is the main association representing psychiatry in Europe. The EPA’s activities address the interests of psychiatrists in academia, research and practice throughout all stages of career development.


European Psychiatric Association (EPA) 

Virtual exhibition

Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN-Europe) Is a patient-driven pan-European organisation, representing and advocating the interests and rights of persons affected by mental ill health. Its main activities relate to advocacy, information, awareness-raising and education and partnership and capacity building. Overarching themes in our work relate to anti-stigma and discrimination and patients’ rights.


Gedeon Richter Plc & RECORDATI S.p.A
Virtual exhibition
Industry Satellite Symposium: ISS.06 — Invitation flyer 
Industry Product Theatre: IPT.05 — Invitation flyer 

Headquartered in Hungary, Gedeon Richter is an innovation-driven specialty pharmaceutical company, boasting the biggest pharmaceutical research centre in CEU. Its latest achievement is the original antipsychotic compound, cariprazine, already marketed in the US for BD and schizophrenia treatment and in majority of the EU countries for the treatment of schizophrenia in adult patients.

Richter Gedeon

Recordati is an international pharmaceutical group, listed on the Italian Stock Exchange, dedicated to the research, development and marketing of pharmaceuticals products. Recordati is committed to the research and development of new specialties in cardiovascular, urological and psychiatric areas with a focus on treatments for rare diseases.


Global Medical Education/Takeda
Industry Satellite Symposium: ISS.01 — Invitation flyer 

Global Medical Education/Sunovion
Industry Satellite Symposium: ISS.03 — Invitation flyer 


Global Medical Education is one of the leading providers of CME in Psychiatry in the USA. It organizes live meetings, satellite symposia, webcasts and enduring content. GME has partnered with the ECNP for the last 4 years to do satellite symposia and science exchange sessions.



H. Lundbeck A/S
Virtual exhibition Otsuka Pharmaceutical Europe Ltd. and H. Lundbeck A/S
Virtual exhibition Progress in Mind Resource Center
Virtual exhibition Lundbeck Institute Campus

Industry Satellite Symposium: ISS.05Invitation flyer
Industry Satellite Symposium: ISS.08 — Invitation flyer

Lundbeck is a global pharmaceutical company specialized in discovering and developing innovative treatments for brain diseases. At Lundbeck, we are tirelessly dedicated to restoring brain health, so every person can be their best. #brainhealth #progressinmind


International Society for CNS Clinical Trials and Methodology (ISCTM)
Virtual exhibition

ISCTM is devoted to advancing clinical research methods related to the development and use of CNS therapeutics. Through its interactive meetings, workshops and webinars ISCTM brings together international stakeholders representing academia, industry, government, payers, policymakers, and the public to address clinical, regulatory, and policy challenges in clinical research.



JAMA Network
Virtual exhibition

JAMA, JAMA Network Open, JAMA Health Forum, and the specialty journals in the JAMA Network provide health care professionals around the world with trusted original research, opinion, education, and multimedia of the highest quality and integrity. Read, view, listen, and learn at


JAMA Network

Janssen Pharmaceutica NV
Virtual exhibition Janssen Schizophrenia
Virtual exhibition Janssen Mood Disorders
Virtual exhibition Janssen Medical Education and Medical Information
Industry Satellite Symposium: ISS.04 — Invitation flyer 
Industry Satellite Symposium: ISS.07Invitation flyer 
Industry Product Theatre: IPT.04 — Invitation flyer 

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
Follow us at
Janssen Pharmaceutica NV is one of the Janssen Pharmaceutical Companies of Johnson & Johnson



Medscape Psychiatry
(unrestricted educational grant from Lundbeck A/S)
Industry Satellite Symposium: ISS.02Invitation flyer 

Medscape is a website providing access to medical information for clinicians; the organization also provides continuing education for physicians and health professionals.


Medscape educational global 

Neuroscience based Nomenclature (NbN)
Virtual exhibition

Neuroscience based Nomenclature (NbN) is a pharmacologically-driven nomenclature for psychiatric medications based on the collaboration of five international organizations. It reflects contemporary neuroscience knowledge and replaces the current indication-based nomenclature. NbN lays the ground for rational, precise prescribing for the clinician and decreases stigma and confusion for the patient.


Neuroscience based Nomenclature (NbN) 

Otsuka Pharmaceutical Development and Commercialization and H. Lundbeck A/S
Industry Satellite Symposium: ISS.08Invitation flyer

Otsuka-Lundbeck-company logo 

Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: 'Otsuka-people creating new products for better health worldwide.'
Otsuka’s 47,000 employees ensure that patients have access to innovative products and medical devices in our key therapy areas of mental health, oncology, cardio-renal and nephrology.

Virtual exhibition SERVIER Marketing
Virtual exhibition SERVIER Medical
Industry Science Exchange: ISE.02Invitation flyer

Servier is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France (Suresnes). With a strong international presence in 150 countries and a total revenue of 4.6 billion euros in 2018-2019, Servier employs 22,000 people worldwide.
The Group invests on average 25% of its total revenue (excluding generic medicines) every year in research and development and uses all its profits for its development.
Corporate growth is driven by Servier’s constant search for innovation in five therapeutic areas: cardiovascular, immune-inflammatory, and neuropsychiatric diseases, metabolism and oncology, as well as by its activities in high-quality generic medicines.

Sunovion Pharmaceuticals Europe Ltd
Virtual exhibition
Industry Satellite Symposium: ISS.09 — Invitation flyer

At Sunovion Pharmaceuticals Europe Ltd., we focus on the introduction and commercialisation of innovative medicines, with a current specialisation in mental health. Sunovion Pharmaceuticals Europe, headquartered in London, is a wholly owned subsidiary of Sunovion Pharmaceuticals Inc.
Sunovion Pharmaceuticals Inc., an indirect, wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., is headquartered in Marlborough, Massachusetts, US.


Sumitomo Dainippon Pharma Co., Ltd., Sunovion Pharmaceuticals Inc. and Angelini Pharma
Industry Satellite Symposium: ISS.09 — Invitation flyer

Sumitomo Dainippon Pharma is among the top-ten listed pharmaceutical companies in Japan, operating globally in major pharmaceutical markets, including Japan, the U.S., China and the European Union. Sumitomo Dainippon Pharma aims to create innovative pharmaceutical products in the Psychiatry & Neurology area, the Oncology area and Regenerative medicine/Cell therapy field, which have been designated as the focus therapeutic areas. Today Sumitomo Dainippon Pharma has more than 6,000 employees worldwide.


Angelini Pharma - Sumitono Dainippon Pharma - Sunovion 

Industry Science Exchange: ISE.03 — Invitation flyer
Industry Science Exchange: ISE.04 — Invitation flyer 

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.


 Shire Denmark - Takeda group

The Lancet
Virtual exhibition

The Lancet family of world-class journals is committed to improving lives through medical research. With offices in London, New York, and Beijing, Lancet journals include The Lancet and monthly specialty journals, such as The Lancet Psychiatry. Learn more at


Upjohn, A Pfizer Division
Industry Science Exchange: ISE.01Invitation flyer

At Upjohn, our mission is relieving the burden of NCDs with trusted, quality medicines for every patient, everywhere.